Cathie Wood’s ARK Invest Sells Over 690,000 Shares of Takeda Pharma

One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold over 690,000 shares of Takeda Pharmaceutical Co. Ltd. (NYSE: TAK) on Tuesday, as the share price of this fund traded was up 2% in the day’s session. Its share price has greatly improved over the past year.

ARK Genomic Revolution ETF (NYSEARCA: ARKG) sold 692,660 shares of Takeda. At Tuesday’s closing price, this would have valued this sale at roughly $9.8 million. This is only a small fraction of the total holdings. This fund is flat over the past 52 weeks.

Here is a quick look at all the other sales that took place across all ARK ETFs:

FundTickerNameShares
ARKFOPENOPENDOOR TECHNOLOGIES166,353
ARKFZZILLOW123,790
ARKGINCYINCYTE6,219
ARKGTAKTAKEDA PHARMACEUTICAL692,660
ARKGVEEVVEEVA SYSTEMS31,755
ARKQLMTLOCKHEED MARTIN4,885
ARKQUUNITY SOFTWARE11,000
ARKWUUNITY SOFTWARE112,381
ARKXHOFPTHALES15,040

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.

ALSO READ: Holiday Shopping Has Exploded Early: 4 Large-Cap Retail Winners to Buy Now


Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use

Source: Read Full Article